Overview
In this study, patients with active mild to moderate UC with or without PSC will be randomized to receive either bromlein or placebo along with low FODMAP diet for 8 weeks.
IBDQ, SCCAIQ, CRP, TAC, TNF-a will be measured before and after the intervention.
Eligibility
Inclusion Criteria:
- active mild to moderate UC
- no other chronic disorders
Exclusion Criteria:
- changed the type and dosage of their medication in the last month
- those who have relapses that required hospitalization and change the type and dosage of medications during the intervention
- patients who do not want to continue the study protocol